Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS

Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS

Background and purpose: Serious adverse events following immunization (AEFI) associated with the COVID-19 vaccines, including BNT162b2 (Pfizer-BioNTech), Ad26.COV2.S (Janssen), and mRNA-1273 (Moderna), have not yet been fully investigated. This study was designed to evaluate the serious AEFI associa...

Full description

Bibliographic Details
Main Authors: Ming-Ming Yan, Hui Zhao, Zi-Ran Li, Jun-Wei Chow, Qian Zhang, Yu-Peng Qi, Shu-Shan Wu, Ming-Kang Zhong, Xiao-Yan Qiu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Pharmacology
Subjects:
COVID-19 vaccine safety
adverse events following immunization
reporting odds ratio
BNT162b2
Ad26.Cov2.S
mRNA-1273
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.921760/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.921760/full

Similar Items